Gene · 51135
Papers3,419
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,419
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Recent advancements in targeted protein knockdown technologies-emerging paradigms for targeted therapy. | Explor Target Antitumor Ther | 2023 | 38213543 | PubTator, text mining | PubMed |
| What happens when Schwann cells are exposed to Mycobacterium leprae - A systematic review. | IBRO Neurosci Rep | 2023 | 38204570 | PubTator, text mining | PubMed |
| Cell Intrinsic Determinants of Alpha Herpesvirus Latency and Pathogenesis in the Nervous System. | Viruses | 2023 | 38140525 | PubTator, text mining | PubMed |
| Knockouts of TNFRSF1A and TNFRSF1B Genes in K562 Cell Line Lead to Diverse Long-Lasting Responses to TNF-α. | Int J Mol Sci | 2023 | 38138998 | PubTator, text mining | PubMed |
| Unraveling Extremely Damaging IRAK4 Variants and Their Potential Implications for IRAK4 Inhibitor Efficacy. | J Pers Med | 2023 | 38138875 | PubTator, text mining | PubMed |
| Exploring Thiazolopyridine AV25R: Unraveling of Biological Activities, Selective Anti-Cancer Properties and In Silico Target and Binding Prediction in Hematological Neoplasms. | Molecules | 2023 | 38138609 | PubTator, text mining | PubMed |
| Rab29-dependent asymmetrical activation of leucine-rich repeat kinase 2. | Science | 2023 | 38127736 | PubTator, text mining | PubMed |
| Novel IRAK4 Inhibitors for Treating Asthma, COPD, Cancer, Autoinflammatory Diseases, and Autoimmune Diseases. | ACS Med Chem Lett | 2023 | 38116447 | PubTator, text mining | PubMed |
| A noncanonical IRAK4-IRAK1 pathway counters DNA damage-induced apoptosis independently of TLR/IL-1R signaling. | Sci Signal | 2023 | 38113335 | PubTator, text mining | PubMed |
| Role of IL-33-ST2 pathway in regulating inflammation: current evidence and future perspectives. | J Transl Med | 2023 | 38082335 | PubTator, text mining | PubMed |
| Linarin Protects Against CCl4-Induced Acute Liver Injury via Activating Autophagy and Inhibiting the Inflammatory Response: Involving the TLR4/MAPK/Nrf2 Pathway. | Drug Des Devel Ther | 2023 | 38076631 | PubTator, text mining | PubMed |
| [Application of PROTACs in Hematological Malignancies--Review]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2023 | 38071084 | PubTator, text mining | PubMed |
| Host Transcriptional Regulatory Genes and Microbiome Networks Crosstalk through Immune Receptors Establishing Normal and Tumor Multiomics Metafirm of the Oral-Gut-Lung Axis. | Int J Mol Sci | 2023 | 38068961 | PubTator, text mining | PubMed |
| Differential Diagnosis: Hepatic Complications in Inborn Errors of Immunity. | J Clin Med | 2023 | 38068532 | PubTator, text mining | PubMed |
| Developing New Strategies for Relapsed/Refractory Diffuse Large B-Cell Lymphoma. | J Clin Med | 2023 | 38068428 | PubTator, text mining | PubMed |
| POU5F1 promotes the proliferation, migration, and invasion of gastric cancer cells by reducing the ubiquitination level of TRAF6. | Cell Death Dis | 2023 | 38062041 | PubTator, text mining | PubMed |
| Utilizing a human TLR selective ligand in a humanized immune system mouse model to investigate human TLR4 signaling. | J Biol Methods | 2023 | 38046987 | PubTator, text mining | PubMed |
| Deep Learning-Driven Library Design for the De Novo Discovery of Bioactive Thiopeptides. | ACS Cent Sci | 2023 | 38033794 | PubTator, text mining | PubMed |
| The Characteristics, Mechanisms and Therapeutics: Exploring the Role of Gut Microbiota in Obesity. | Diabetes Metab Syndr Obes | 2023 | 38028999 | PubTator, text mining | PubMed |
| Too much of a good thing: a review of primary immune regulatory disorders. | Front Immunol | 2023 | 38022498 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51135/papers?page=12